Spoken Alpha
CGEM
Cullinan Therapeutics, Inc.
Overview
Cullinan Therapeutics, Inc is a Healthcare company operating in Biotechnology with a $1.27B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-08-30.
Transcripts
Recent earnings calls
No earnings calls indexed for CGEM yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add CGEM, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-11-04EPS— vs $-0.79—Rev— vs ——EODHD
- Q2 FY20262026-08-05EPS$-0.81 vs $-0.71-14.1%Rev$0 vs ——EODHD
- Q1 FY20262026-05-06EPS$-0.75 vs $-0.84+10.7%Rev$0 vs ——EODHD
- Q4 FY20252026-03-04EPS$-0.77 vs $-0.87+11.9%Rev$0 vs ——EODHD
- Q3 FY20252025-11-05EPS$-0.77 vs $-0.89+13.5%Rev$0 vs ——EODHD
- Q2 FY20252025-08-06EPS$-1.07 vs $-0.83-28.9%Rev$0 vs ——EODHD
- Q1 FY20252025-05-07EPS$-0.74 vs $-0.81+8.6%Rev$0 vs ——EODHD
- Q4 FY20242025-03-11EPS$-0.73 vs $-0.74+1.7%Rev$0 vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.69 vs $-0.77+10.4%Rev$0 vs ——EODHD
- Q2 FY20242024-08-07EPS$-0.75 vs $-0.73-2.7%Rev$0 vs ——EODHD
- Q1 FY20242024-05-14EPS$-0.86 vs $-0.99+13.1%Rev$0 vs ——EODHD
- Q4 FY20232024-03-13EPS$-0.54 vs $-0.98+44.9%Rev$0 vs ——EODHD
- Q3 FY20232023-11-07EPS$-0.91 vs $-0.94+3.2%Rev$0 vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.82 vs $-1.00+18.0%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-1.42 vs $-0.98-44.9%Rev$0 vs ——EODHD
- Q4 FY20222023-03-08EPS$-0.59 vs $-0.71+16.9%Rev$0 vs ——EODHD
- Q3 FY20222022-11-13EPS$-0.54 vs $-0.97+44.3%Rev$0 vs ——EODHD
- Q2 FY20222022-08-09EPS$3.77 vs $5.42-30.4%Rev$0 vs ——EODHD
- Q1 FY20222022-05-15EPS$-0.27 vs $-0.55+50.9%Rev$0 vs ——EODHD
- Q4 FY20212022-03-16EPS$-0.74 vs $-0.47-57.5%Rev$-37.8M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $-0.79 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-0.81 | $-0.71 | -14.1% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-0.75 | $-0.84 | +10.7% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-04 | $-0.77 | $-0.87 | +11.9% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-0.77 | $-0.89 | +13.5% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-1.07 | $-0.83 | -28.9% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-0.74 | $-0.81 | +8.6% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-11 | $-0.73 | $-0.74 | +1.7% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.69 | $-0.77 | +10.4% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.75 | $-0.73 | -2.7% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-0.86 | $-0.99 | +13.1% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-13 | $-0.54 | $-0.98 | +44.9% | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.91 | $-0.94 | +3.2% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.82 | $-1.00 | +18.0% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-1.42 | $-0.98 | -44.9% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-08 | $-0.59 | $-0.71 | +16.9% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-0.54 | $-0.97 | +44.3% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-09 | $3.77 | $5.42 | -30.4% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-15 | $-0.27 | $-0.55 | +50.9% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-16 | $-0.74 | $-0.47 | -57.5% | $-37.8M | — | — | EODHD |
Source: EODHD. CGEM reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Nadim AhmedCEO4 yr 11 mono recorded callsCurrent
- Mary Kay FentonCFO2 yr 5 mono recorded callsCurrent
- Jennifer MichaelsonChief Scientific Officer2 yr 9 mono recorded callsCurrent
- Corrine SavillChief Business Officer3 yr 7 mono recorded callsCurrent
- Jacquelyn L SumerChief Legal Officer4 yr 1 mono recorded callsCurrent
- Jeffrey Alan JonesChief Medical Officer4 yr 7 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CGEM.
$ curl https://api.spokenalpha.com/v1/companies/CGEMFAQ
Frequently asked about CGEM
Where can I find Cullinan Therapeutics, Inc.'s (CGEM) earnings call transcripts?
Spoken Alpha indexes CGEM's earnings call transcripts at https://spokenalpha.com/companies/CGEM. Each call links to attributed speakers and parsed analyst Q&A. Cullinan Therapeutics, Inc.'s own investor relations page is at https://investors.cullinantherapeutics.com/.
What sector is CGEM in?
Cullinan Therapeutics, Inc. (CGEM) operates in the Healthcare sector (Biotechnology industry).